BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KB407 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KB407\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05504837-10806@assetmemo.bio
DTSTAMP:20261121T005428Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:KB407: Phase 1 readout est. (NCT05504837)
DESCRIPTION:KB407\, phase 1\, Cystic Fibrosis.\nStudy: A Study Assessing KB
 407 for the Treatment of Cystic Fibrosis\nEstimated primary completion: De
 cember 2026. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/kb407#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT055048
 37
URL:https://assetmemo.bio/drug/kb407#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
